Therapeutic approaches for refractory germ cell cancer-Reference-Cited by-同舟云学术

Therapeutic approaches for refractory germ cell cancer

Published:2018-03-12 Issue:4 Volume:18 Page:389-397
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Oing Christoph¹^ORCID,Seidel Christoph¹,Bokemeyer Carsten¹

Affiliation:

1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1450630

Reference87 articles.

1. Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing

2. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

3. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis

4. Testicular germ-cell cancer

5. Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis and pathobiology of testicular germ cell tumours: a view from a developmental biological perspective with guidelines for pathological diagnostics;Histopathology;2024-06-24

2. Ovarian tumors in the pediatric population: An update;Disease-a-Month;2024-06

3. EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors;Andrology;2024-02-21

4. Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors;Journal of Clinical Medicine;2023-11-13

5. Molecular Biomarkers With Potential Clinical Application in Testicular Cancer;Modern Pathology;2023-10